At its chemical park in Marl, Germany, Evonik has brought on stream a new 40,000 t/y plant for its "Elatur" phthalate-free plasticizer 1.2-cyclohexa dicarboxylic acid diisononyl ester. Investment is said to be in the "double-digit million euro range." The German group said it is talking with potential partners about launching a range of bio-based plasticisers under the same name.
Compelling solutions through strategic partnerships
Novo Nordisk announced a global workforce reduction of approximately 9,000 positions to streamline operations and reinvest DKK 8 billion (€1 billion) in growth opportunities for diabetes and obesity treatments.
Building on the April 2025 announcement, Dow will take actions across its three operating segments to support European profitability, resulting in the closure of sites in Germany and the UK.
BASF sells a majority stake in its coatings business to the investor Carlyle.
Merck to acquire the chromatography business of JSR Life Sciences, a leading provider of CDMO services, preclinical and translational clinical research, and bioprocessing solutions.
